1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. Xbrane Bioscience AB Acquires Primm Pharma Srl

M&A Deal Summary

Xbrane Bioscience AB Acquires Primm Pharma Srl

On October 14, 2015, Xbrane Bioscience AB acquired life science company Primm Pharma Srl

Acquisition Highlights
  • This is Xbrane Bioscience AB’s 1st transaction in the Life Science sector.
  • This is Xbrane Bioscience AB’s 1st transaction in Italy.

M&A Deal Summary
Date 2015-10-14
Target Primm Pharma Srl
Sector Life Science
Buyer(s) Xbrane Bioscience AB
Deal Type Add-on Acquisition

Target

Primm Pharma Srl

Milan, Italy
Primm Pharma Srl is specialized in the development and production of pharmaceutical formulations for slow release injections and has a portfolio currently consisting of five slow release biogeneric candidates.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Xbrane Bioscience AB

Stockholm, Sweden
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

Xbrane Bioscience AB is a biopharmaceutical company specialized in High Demand Complex Generics.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal